BenQ Medical Technology (4116) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 明基醫

BenQ Medical Technology (4116) reported revenue of NT$444.2 million for Oct 2026, +2.1% year on year and +5.5% from the previous month. Revenue for Jan–Oct 2026 was NT$4.47 billion (+3.6% year on year).

In Oct 2026, it ranked No. 19 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$414 million24/10Nov 2024 NT$461.6 millionDec 2024 NT$437.3 millionJan 2025 NT$411.3 millionFeb 2025 NT$391 million25/02Mar 2025 NT$425.6 millionApr 2025 NT$442.9 millionMay 2025 NT$451.3 millionJun 2025 NT$440.8 million25/06Jul 2025 NT$461.9 millionAug 2025 NT$414.1 millionSep 2025 NT$440.3 millionOct 2025 NT$434.8 million25/10Nov 2025 NT$441.3 millionDec 2025 NT$499.1 millionJan 2026 NT$493.8 millionFeb 2026 NT$381.9 million26/02Mar 2026 NT$448.9 millionApr 2026 NT$506.9 millionMay 2026 NT$456.7 millionJun 2026 NT$465.5 million26/06Jul 2026 NT$431.4 millionAug 2026 NT$417.7 millionSep 2026 NT$421 millionOct 2026 NT$444.2 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$444.2 million+2.1%+5.5%
Sep 2026NT$421 million-4.4%+0.8%
Aug 2026NT$417.7 million+0.9%-3.2%
Jul 2026NT$431.4 million-6.6%-7.3%
Jun 2026NT$465.5 million+5.6%+1.9%
May 2026NT$456.7 million+1.2%-9.9%
Apr 2026NT$506.9 million+14.5%+12.9%
Mar 2026NT$448.9 million+5.5%+17.5%
Feb 2026NT$381.9 million-2.3%-22.7%
Jan 2026NT$493.8 million+20.1%-1.1%
Dec 2025NT$499.1 million+14.1%+13.1%
Nov 2025NT$441.3 million-4.4%+1.5%
Oct 2025NT$434.8 million+5.0%-1.2%
Sep 2025NT$440.3 million+3.2%+6.3%
Aug 2025NT$414.1 million+2.6%-10.4%
Jul 2025NT$461.9 million+20.1%+4.8%
Jun 2025NT$440.8 million+9.6%-2.3%
May 2025NT$451.3 million+16.1%+1.9%
Apr 2025NT$442.9 million+15.0%+4.1%
Mar 2025NT$425.6 million+16.1%+8.9%
Feb 2025NT$391 million+21.5%-4.9%
Jan 2025NT$411.3 million+11.6%-5.9%
Dec 2024NT$437.3 million+5.2%-5.3%
Nov 2024NT$461.6 million+15.8%+11.5%
Oct 2024NT$414 million+5.0%-3.0%

Jan–Oct 2026 cumulative: NT$4.47 billion (+3.6% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: BenQ Medical Technology vs PEC / BenQ Medical Technology vs Lotus Pharm / BenQ Medical Technology vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16